Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

73.03 -0.20 (-0.27%)
Official Closing Price Updated: 4:10 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,700,376
Open 72.95
Bid (Size) 72.91 (12)
Ask (Size) 73.04 (1)
Prev. Close 73.23
Today's Range 72.10 - 73.17
52wk Range 63.80 - 92.60
Shares Outstanding 816,750
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
U.S. stocks experienced a welcome resurgence on Tuesday, buoyed by the latest comments from Federal Reserve officials. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Biotech And Healthcare Portfolio Playbook For December 2023/24
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets

Performance

YTD
-10.43%
-10.43%
1 Month
+12.03%
+12.03%
3 Month
-7.47%
-7.47%
6 Month
-12.16%
-12.16%
1 Year
-8.31%
-8.31%

More News

Read More
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
Via Talk Markets
Topics ETFs
3 Biotech Stocks That Could Boom or Bust by 2025
Via InvestorPlace
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Via Talk Markets
Exposures COVID-19
This Week’s Data Dump May Lead To More Stock Market Pain
Via Talk Markets
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Via The Motley Fool
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
Via Talk Markets
Topics Economy
Exposures Economy
Thoughts For Thursday: War Worries Rattle The Market
Via Talk Markets
Too Much To Handle For Stocks As Rates Continue To Rise
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
Stocks and Bonds Go Their Separate Ways
Via Talk Markets
Topics Stocks
Exposures US Equities
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
Via Talk Markets
Stocks Rally And Rates Drop But Trends Remain In Place
Via Talk Markets
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
Via InvestorPlace
Topics ETFs
Healthcare Playbook Revisited - Growth Plus Value
Via Talk Markets
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
Via InvestorPlace
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Via Benzinga
Healthcare Portfolio: A Mixed Market Looking for Value
Via Talk Markets
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
Via Talk Markets
Topics ETFs
Exposures COVID-19
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
Via Benzinga
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
Via InvestorPlace
5 Meme Stocks to Sell Immediately, According to AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
Via Talk Markets
3 Biotech Stocks to Buy for Long-Term Gains
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
“The Secret To Happiness” Stock Market (And Sentiment Results)
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.